Inmedix charity golf event raises $43,695 for Seattle Children’s

Inmedix says its 10th annual charity golf tournament brought in $43,695.44 for the Pediatric Rheumatology Division at Seattle Children’s, pushing total support past $250,000 over 10 years. The company says the funds help children with arthritis and autoimmune disease while its FDA-cleared CloudHRV product moves into clinical use.

Why it matters: - Inmedix says the fundraiser supports research and other urgent needs for children with arthritis and autoimmune disease at Seattle Children’s. - The 10-year total now stands at just over $250,000, giving the Pediatric Rheumatology Division a steady outside funding source. - The event also reflects how Inmedix ties community giving to its broader focus on autonomic nervous system and heart rate variability diagnostics.

What happened: - Inmedix held its 10th annual charity golf tournament on Aug. 31, 2026, at the Club at Snoqualmie Ridge. - The company announced a final fundraising total of $43,695.44 from the event. - After 10 annual events, Inmedix says cumulative support for Seattle Children’s has reached just over $250,000. - The 11th annual Inmedix Charity Golf event is planned for late August 2027.

The details: - Inmedix says all entry checks are made out to Seattle Children’s so collected fees go 100% to support kids with arthritis. - After golf and the awards banquet, the full bill is sent to Inmedix, the event’s sole sponsor. - The company says it began providing its CloudHRV diagnostic to clinicians after FDA clearance in January 2025. - CloudHRV is described as the first FDA-cleared cloud-based heart rate variability diagnostic calculated from a high-fidelity 5-minute electrocardiogram and including Baevsky indices of parasympathetic and sympathetic activity. - Inmedix says the system is intended to improve validation, scalability, precision and affordability in clinical HRV assessment. - The company and its subsidiary, Inmedix UK, Ltd., say they focus on research tied to stress and autonomic nervous system biology.

Between the lines: - The fundraiser gives Inmedix a public-facing philanthropic role alongside its clinical technology business. - The repeated annual event suggests the company sees Seattle Children’s as a long-term community partner, not a one-off beneficiary. - Andrew J. Holman, MD, said the charity effort began years before Inmedix revenue and before the commercial launch of FDA-cleared CloudHRV. - Holman said the project has been one of Inmedix’s most important milestones.

What’s next: - Inmedix is preparing for the 11th annual charity golf event in late August 2027. - The company says it will continue supporting Seattle Children’s Pediatric Rheumatology Division through future events. - Inmedix also says its next steps include additional work around preclinical studies and product capabilities, according to the release’s forward-looking statement.

The bottom line: - Inmedix has turned a golf tournament into a multi-year funding stream for pediatric rheumatology while its FDA-cleared CloudHRV platform enters clinical use. - More information is available on Andrew Holman’s LinkedIn profile.